MEDIVATION, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 11 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-09-15: Reporting owner Cohen Cheryl; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-07-26: Reporting owner Seely Lynn; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-07-15: Reporting owner BLICKENSTAFF KIM D; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-07-15: Reporting owner Adams Daniel; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-09-15 | Cohen Cheryl Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $19.21 exercise price | 2011-09-16 | |
| 2011-07-26 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,600 54,000 owned after | $34.56 exercise price | 2012-07-27 | |
| 2011-07-15 | BLICKENSTAFF KIM D Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.00 exercise price | 2011-07-18 | |
| 2011-07-15 | Adams Daniel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.00 exercise price | 2011-07-18 | |
| 2011-07-15 | VERNON W ANTHONY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.00 exercise price | 2011-07-18 | |
| 2011-07-15 | Bailey Gregory Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.00 exercise price | 2011-07-18 | |
| 2011-04-20 | PALEKAR ROHAN Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 245,000 owned after | $15.71 exercise price | 2011-04-21 | |
| 2011-03-15 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 66,000 owned after | $3.60 exercise price | 2011-03-17 | |
| 2011-02-15 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 116,000 owned after | $3.60 exercise price | 2011-02-16 | |
| 2011-01-19 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 166,000 owned after | $3.60 exercise price | 2011-01-20 | |
| 2011-01-18 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 191,000 owned after | $3.60 exercise price | 2011-01-20 |